Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review)
- 1 April 2024
- journal article
- review article
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 94 (4) , 989-1005
Abstract
Cancer, which proliferates and spreads uncontrollably due to the accumulation of genetic and epigenetic factors, is one of the most fatal diseases. Cancer management meets multiple obstacles, and resistance to current therapeutic approaches is the major one. Pyridines/quinolines and sulfonamides can exert the anticancer potential through different mechanisms, and many current available anticancer chemotherapeutics own a pyridine/quinoline or sulfonamide moiety, revealing that pyridine/quinoline and sulfonamide motifs are useful pharmacophores for the discovery of novel anticancer agents. Notably, incorporation of pyridine/quinoline and sulfonamide pharmacophores into one molecule is a promising strategy to overcome drug resistance, improve the activity and reduce the toxicity since pyridine/quinoline-sulfonamide hybrids could simultaneously act on dual/multiple targets in cancer cells. This review outlines the current scenario of pyridine/quinoline-sulfonamide hybrids with the anticancer potential, covering articles published from 2020 onwards, to pave the way for the development of novel more effective and multitargeted anticancer candidates.Keywords
This publication has 66 references indexed in Scilit:
- Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional NanomaterialsSmall Methods, 2023
- Potential reaction initiation points of polycyclic aromatic hydrocarbonsArabian Journal of Chemistry, 2022
- Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastomaActa Pharmaceutica Sinica B, 2021
- Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600EinhibitorsBioorganic Chemistry, 2021
- Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancerBioorganic Chemistry, 2021
- Novel N-(aryl/heteroaryl)-2-chlorobenzenesulfonamide derivatives: Synthesis and anticancer activity evaluationBioorganic Chemistry, 2020
- Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analysesBioorganic Chemistry, 2020
- Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesteraseBioorganic Chemistry, 2020
- Design, synthesis, and evaluations of the antiproliferative activity and aqueous solubility of novel carbazole sulfonamide derivatives as antitumor agentsBioorganic Chemistry, 2020
- Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapyBioorganic Chemistry, 2020